Equities Research Analysts’ Updated EPS Estimates for March 25th (ABSI, ACHV, ALNY, AMLX, ARE, ARM, ARWR, ASC, BMEA, BNTX)

Equities Research Analysts’ updated eps estimates for Wednesday, March 25th:

Absci (NASDAQ:ABSI) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $7.00 target price on the stock.

Achieve Life Sciences (NASDAQ:ACHV) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $12.00 price target on the stock.

Alnylam Pharmaceuticals (NASDAQ:ALNY) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $510.00 price target on the stock.

Amylyx Pharmaceuticals (NASDAQ:AMLX) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $34.00 target price on the stock.

Alexandria Real Estate Equities (NYSE:ARE) had its market perform rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $52.00 target price on the stock, down from their previous target price of $65.00.

ARM (NASDAQ:ARM) had its buy rating reaffirmed by analysts at Rosenblatt Securities. They currently have a $175.00 price target on the stock.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its buy rating reissued by analysts at HC Wainwright. They currently have a $100.00 target price on the stock.

ASOS (LON:ASC) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 600 price target on the stock.

Biomea Fusion (NASDAQ:BMEA) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $12.00 target price on the stock.

BioNTech (NASDAQ:BNTX) had its buy rating reissued by analysts at Jefferies Financial Group Inc..

Braze (NASDAQ:BRZE) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $38.00 price target on the stock.

Braze (NASDAQ:BRZE) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $50.00 price target on the stock.

Bellway (LON:BWY) had its sector perform rating reiterated by analysts at Royal Bank Of Canada. They currently have a GBX 3,150 price target on the stock.

Bytes Technology Group (LON:BYIT) had its hold rating reiterated by analysts at Shore Capital Group Ltd.

Blaize (NASDAQ:BZAI) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $6.00 target price on the stock.

Cipher Mining (NASDAQ:CIFR) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $22.00 price target on the stock.

Crescent Energy (NYSE:CRGY) had its accumulate rating reissued by analysts at Johnson Rice. Johnson Rice currently has a $19.00 target price on the stock.

Craneware (LON:CRW) had its buy rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a GBX 570 price target on the stock.

EnQuest (LON:ENQ) had its buy rating reaffirmed by analysts at Shore Capital Group Ltd.

EVgo (NASDAQ:EVGO) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co..

European Wealth Group (LON:EWG) had its neutral rating reaffirmed by analysts at UBS Group AG. UBS Group AG currently has a GBX 142 target price on the stock.

Franchise Brands (LON:FRAN) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 185 target price on the stock.

Gamma Communications (LON:GAMA) had its buy rating reissued by analysts at Shore Capital Group Ltd.

Composecure (NYSE:GPGI) had its buy rating reiterated by analysts at Needham & Company LLC.

GSK (LON:GSK) had its buy rating reaffirmed by analysts at Shore Capital Group Ltd.

Home Depot (NYSE:HD) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $435.00 price target on the stock.

Hoth Therapeutics (NASDAQ:HOTH) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $5.00 target price on the stock.

3i Group (LON:III) had its buy rating reiterated by analysts at UBS Group AG. The firm currently has a GBX 4,000 target price on the stock.

Incyte (NASDAQ:INCY) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $135.00 price target on the stock.

Kodiak AI (NASDAQ:KDK) had its buy rating reissued by analysts at Chardan Capital. Chardan Capital currently has a $22.00 price target on the stock.

Kingfisher (LON:KGF) had its neutral rating reiterated by analysts at UBS Group AG. They currently have a GBX 315 target price on the stock.

Kestra Medical Technologies (NASDAQ:KMTS) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $32.00 target price on the stock.

Maze Therapeutics (NASDAQ:MAZE) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $46.00 price target on the stock.

Spectral AI (NASDAQ:MDAI) had its buy rating reissued by analysts at BTIG Research. They currently have a $3.00 target price on the stock.

Mondelez International (NASDAQ:MDLZ) had its neutral rating reiterated by analysts at Rothschild & Co Redburn. The firm currently has a $55.00 target price on the stock, down from their previous target price of $71.00.

NeuroSense Therapeutics (NASDAQ:NRSN) had its buy rating reissued by analysts at D. Boral Capital. The firm currently has a $14.00 price target on the stock.

NEXT (LON:NXT) had its buy rating reaffirmed by analysts at UBS Group AG. The firm currently has a £152 target price on the stock.

Phunware (NASDAQ:PHUN) had its neutral rating reiterated by analysts at HC Wainwright. They currently have a $2.00 target price on the stock.

Palantir Technologies (NASDAQ:PLTR) had its buy rating reiterated by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $200.00 target price on the stock.

The Boutique Group (LON:TBTG) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 450 target price on the stock.

Terns Pharmaceuticals (NASDAQ:TERN) had its neutral rating reaffirmed by analysts at HC Wainwright. The firm currently has a $53.00 price target on the stock.

TT Electronics (LON:TTG) had its hold rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 120 target price on the stock.

W.R. Berkley (NYSE:WRB) was downgraded by analysts at Brean Capital from a buy rating to a neutral rating. They currently have $73.00 price target on the stock.

Western Copper and Gold (NYSEAMERICAN:WRN) (TSE:WRN) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $5.75 target price on the stock.

YouGov (LON:YOU) had its buy rating reiterated by analysts at UBS Group AG. The firm currently has a GBX 510 target price on the stock.

Zillow Group (NASDAQ:ZG) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $95.00 target price on the stock.